PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics

Starting soon · Not applicable

Conditions studied: Traumatic Brain Injury, Magnetic Resonance Imaging (MRI)

In brief

Traumatic brain injury (TBI) represent a major public health issue, accounting for approximately 1.5 million hospital admissions annually across the European Union and 160,000 cases in France. They are a significant cause of mortality and disability, with serious consequences for patients and their families. Predicting functional outcomes remains complex due to the heterogeneity of brain injuries, whether primary or secondary, as well as the mechanisms involved, particularly neuroinflammation. This difficulty is particularly pronounced for moderate to severe TBI, for which current predictive tools are still limited. The PASTRAMI project proposes to utilise diffusion magnetic resonance imaging (MRI) to identify biomarkers associated with axonal lesions in the white matter. This technique enables the analysis of brain microstructure and the reconstruction of neural connections (connectome), thereby offering innovative prospects for improving the prediction of functional recovery. This is a prospective, multicentre, interventional study involving 100 patients aged between 18 and 60 years with moderate to severe traumatic brain injury. The primary objective is to assess the prognostic value of brain microstructural measures at baseline, by correlating them with the GOSE functional score at 1 year. Secondary objectives include the analysis of mortality, functional outcome, quality of life, and early physiological factors influencing progression. Patients will undergo a standard MRI scan supplemented with additional sequences for prognostic purposes, without any change to their therapeutic management. The associated risks are minimal and relate primarily to the MRI scan. No immediate individual benefit is expected, but the results could improve our understanding of brain lesions and optimise future management. The total duration of the study is 48 months. The expected outcomes include better characterisation of lesions and improved predictive tools, contributing to more appropriate clinical decisions.

Key facts

Study ID: NCT07527949
Run by: Rennes University Hospital
People needed: 100
Starts: 2026-09-01
Expected to finish: 2030-09-01
Last updated by the study team: 2026-06-12

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Aged 18 to 60
Admitted for moderate to severe non-penetrating head injury (with a Glasgow Coma Scale score ≤ 12)
On mechanical ventilation and under continuous sedation
Enrolled in a social security program
Whose family has been informed and has signed a voluntary, informed, written consent form

You may not qualify if…

History of head trauma, stroke, or neurodegenerative diseases
A decision to limit active treatment has already been made
Quadriplegia
Contraindications to MRI
Protected individuals (adults under legal protection [judicial protection, guardianship, conservatorship], individuals deprived of liberty, pregnant women [self-reported], breastfeeding women, and minors).

Where it is running

Centre Hospitalier Universitaire de Rennes Service de réanimation — Rennes, France
HIA Sainte Anne, BCRM Toulon Service de réanimation — Toulon, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.